These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 33433179)
21. Development and process evaluation of an educational intervention for overdose prevention and naloxone distribution by general practice trainees. Klimas J; Egan M; Tobin H; Coleman N; Bury G BMC Med Educ; 2015 Nov; 15():206. PubMed ID: 26590066 [TBL] [Abstract][Full Text] [Related]
22. Naloxone without the needle - systematic review of candidate routes for non-injectable naloxone for opioid overdose reversal. Strang J; McDonald R; Alqurshi A; Royall P; Taylor D; Forbes B Drug Alcohol Depend; 2016 Jun; 163():16-23. PubMed ID: 26996745 [TBL] [Abstract][Full Text] [Related]
23. Survey of Southern Wisconsin Needle Exchange Clients Regarding Opioid Overdose and Naloxone Use. Baltes A; Devo B; Kaiser M; Birstler J; Brown RT WMJ; 2019 Jul; 118(2):84-87. PubMed ID: 31532934 [TBL] [Abstract][Full Text] [Related]
24. Relay: A Peer-Delivered Emergency Department-Based Response to Nonfatal Opioid Overdose. Welch AE; Jeffers A; Allen B; Paone D; Kunins HV Am J Public Health; 2019 Oct; 109(10):1392-1395. PubMed ID: 31415200 [TBL] [Abstract][Full Text] [Related]
25. Revisiting Naloxone: A different take on overdose guidelines from Lee County, Fla. Hamel MG JEMS; 2016 Nov; 41(11):46-8. PubMed ID: 29188963 [No Abstract] [Full Text] [Related]
26. Naloxone for Outpatients at Risk of Opioid Overdose #328. Chwistek M; Wolf M J Palliat Med; 2017 May; 20(5):562-563. PubMed ID: 28296569 [No Abstract] [Full Text] [Related]
27. Naloxone distribution, trauma, and supporting community-based overdose responders. Shearer D; Fleming T; Fowler A; Boyd J; McNeil R Int J Drug Policy; 2019 Dec; 74():255-256. PubMed ID: 30527865 [No Abstract] [Full Text] [Related]
28. Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose. Krieter P; Chiang N; Gyaw S; Skolnick P; Crystal R; Keegan F; Aker J; Beck M; Harris J J Clin Pharmacol; 2016 Oct; 56(10):1243-53. PubMed ID: 27145977 [TBL] [Abstract][Full Text] [Related]
30. Rapid widespread distribution of intranasal naloxone for overdose prevention. Madah-Amiri D; Clausen T; Lobmaier P Drug Alcohol Depend; 2017 Apr; 173():17-23. PubMed ID: 28182982 [TBL] [Abstract][Full Text] [Related]
31. Higher naloxone dosing may be required for opioid overdose. Bardsley R Am J Health Syst Pharm; 2019 Oct; 76(22):1835-1837. PubMed ID: 31665765 [TBL] [Abstract][Full Text] [Related]
32. The feasibility of employing a home healthcare model for education and treatment of opioid overdose using a naloxone auto-injector in a private practice pain medicine clinic. Dragovich A; Brason F; Beltran T; McCoart A; Plunkett AR Curr Med Res Opin; 2018 Dec; 34(12):2137-2141. PubMed ID: 29667452 [TBL] [Abstract][Full Text] [Related]
33. Intravenous use of intranasal naloxone: A case of overdose reversal. Das S; Shah N; Ghadiali M Subst Abus; 2017; 38(1):18-21. PubMed ID: 27925864 [TBL] [Abstract][Full Text] [Related]
34. Intranasal naloxone soon to become part of evolving clinical practice around opioid overdose prevention. Dietze P; Cantwell K Addiction; 2016 Apr; 111(4):584-6. PubMed ID: 26995168 [No Abstract] [Full Text] [Related]
36. Rethinking Naloxone: Overdose drug is only one part of the cycle of narcotic abuse. Richmond NJ JEMS; 2017 Feb; 42(2):63. PubMed ID: 29215840 [No Abstract] [Full Text] [Related]